Marksans Pharma Limited has informed the Exchange about Audio Recording of investor(s) / analyst(s) meet Conference Call on Q3 & 9M FY26 Financial Results
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has shared the audio recording of its conference call with investors and analysts held to discuss the Q3 and nine-month FY26 financial results. The recording is being made available through the stock exchange as part of compliance with listing requirements. No specific financial numbers or management commentary are included in the filing itself — investors need to listen to the call for detailed insights. The call likely covered business performance, segment updates, and outlook for the remaining part of FY26.
Neutral to mildly positive for transparency — sharing the audio recording improves access to management commentary for retail investors who missed the live call. The actual stock impact will depend on what management said during the call, which is not captured in this filing.